Jack Shireman

680 total citations
24 papers, 403 citations indexed

About

Jack Shireman is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Jack Shireman has authored 24 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Jack Shireman's work include Glioma Diagnosis and Treatment (16 papers), Immunotherapy and Immune Responses (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Jack Shireman is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Immunotherapy and Immune Responses (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Jack Shireman collaborates with scholars based in United States, Germany and Singapore. Jack Shireman's co-authors include Atique U. Ahmed, Mahua Dey, Shivani Baisiwala, Seamus P. Caragher, Maciej S. Lesniak, C. David James, Fatemeh Atashi, Jason Miska, Gina Lee and Craig Horbinski and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Brain.

In The Last Decade

Jack Shireman

20 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Shireman United States 12 197 178 93 89 86 24 403
Seamus P. Caragher United States 9 172 0.9× 189 1.1× 52 0.6× 89 1.0× 78 0.9× 13 376
Christin Schmidt Germany 7 175 0.9× 150 0.8× 123 1.3× 62 0.7× 89 1.0× 12 382
Tobias Bergström Sweden 10 176 0.9× 119 0.7× 68 0.7× 55 0.6× 71 0.8× 17 355
Ruifan Xie China 11 189 1.0× 131 0.7× 45 0.5× 99 1.1× 85 1.0× 19 372
Diane D. Mao United States 11 242 1.2× 128 0.7× 102 1.1× 150 1.7× 104 1.2× 16 482
Jee Ye Kahng South Korea 2 199 1.0× 268 1.5× 39 0.4× 76 0.9× 137 1.6× 3 441
Nicolas Goffart Belgium 9 141 0.7× 187 1.1× 63 0.7× 100 1.1× 63 0.7× 12 345
Dirk C. Hoffmann Germany 10 141 0.7× 108 0.6× 42 0.5× 69 0.8× 51 0.6× 20 302
Isabele Cristiana Iser Brazil 12 272 1.4× 221 1.2× 108 1.2× 140 1.6× 147 1.7× 18 641
Jonas Blaes Germany 9 192 1.0× 143 0.8× 56 0.6× 128 1.4× 95 1.1× 14 434

Countries citing papers authored by Jack Shireman

Since Specialization
Citations

This map shows the geographic impact of Jack Shireman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Shireman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Shireman more than expected).

Fields of papers citing papers by Jack Shireman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Shireman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Shireman. The network helps show where Jack Shireman may publish in the future.

Co-authorship network of co-authors of Jack Shireman

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Shireman. A scholar is included among the top collaborators of Jack Shireman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Shireman. Jack Shireman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shireman, Jack, et al.. (2025). CASSIA: a multi-agent large language model for automated and interpretable cell annotation. Nature Communications. 17(1). 389–389. 1 indexed citations
2.
Shireman, Jack, et al.. (2025). TMOD-29. Animal Free Modeling of Diffuse Intrinsic Pontine Glioma using a Human Neural Organoid. Neuro-Oncology. 27(Supplement_5). v480–v480.
3.
Shireman, Jack, Simon G. Ammanuel, & Mahua Dey. (2025). Advancing Glioma Management: The Pivotal Role of Surgical Neuro-Oncology in Driving Innovation and Translational Research. Current Oncology Reports. 27(4). 446–457.
4.
Shireman, Jack, et al.. (2024). Transcriptomic and proteomic spatial profiling of pediatric and adult diffuse midline glioma H3 K27-Altered. Scientific Reports. 14(1). 22668–22668. 2 indexed citations
5.
Zhao, Lei, Jack Shireman, Xiaohu Wang, et al.. (2024). CCL21 Induces Plasmacytoid Dendritic Cell Migration and Activation in a Mouse Model of Glioblastoma. Cancers. 16(20). 3459–3459.
6.
Agrawal, Namita, Jack Shireman, Kevin Shiue, et al.. (2024). Preoperative stereotactic radiosurgery for patients with 1–4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694). Neuro-Oncology Practice. 11(5). 593–603. 5 indexed citations
8.
Shireman, Jack, Eunüs S. Ali, Shivani Baisiwala, et al.. (2023). Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Science Advances. 9(20). eade7236–eade7236. 18 indexed citations
9.
Shireman, Jack, et al.. (2023). Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?. Frontiers in Oncology. 13. 1266397–1266397. 2 indexed citations
10.
Bradford, Daniel E., et al.. (2022). Alcohol’s Effects During Uncertain and Uncontrollable Stressors in the Laboratory. Clinical Psychological Science. 10(5). 885–900. 4 indexed citations
11.
Shireman, Jack, et al.. (2022). Surgical Neuro-Oncology. Neurologic Clinics. 40(2). 437–453. 9 indexed citations
12.
Shireman, Jack, Fatemeh Atashi, Gina Lee, et al.. (2021). De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain. 144(4). 1230–1246. 46 indexed citations
13.
Lara‐Velazquez, Montserrat, Jack Shireman, Eric J. Lehrer, et al.. (2021). A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 662302–662302. 13 indexed citations
14.
Shireman, Jack, et al.. (2021). Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance. Frontiers in Cellular Neuroscience. 15. 716947–716947. 20 indexed citations
15.
Huff, Wei, Marpe Bam, Jack Shireman, et al.. (2021). Aging- and Tumor-Mediated Increase in CD8+CD28− T Cells Might Impose a Strong Barrier to Success of Immunotherapy in Glioblastoma. ImmunoHorizons. 5(6). 395–409. 20 indexed citations
16.
Baisiwala, Shivani, Jack Shireman, Cheol Park, et al.. (2020). LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma. Cancers. 12(12). 3505–3505. 14 indexed citations
17.
Caragher, Seamus P., Jack Shireman, Fatemeh Atashi, et al.. (2019). Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Cell Death and Disease. 10(4). 292–292. 60 indexed citations
18.
Caragher, Seamus P., Jack Shireman, Mei Huang, et al.. (2019). Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma. Journal of Neuroscience. 39(11). 1982–1993. 68 indexed citations
19.
Ahmed, Atique U., Jack Shireman, Fatemeh Atashi, et al.. (2019). OS6.1 Targeting Purine Metabolism to Overcome Therapeutic Resistance in Glioblastoma. Neuro-Oncology. 21(Supplement_3). iii12–iii12. 1 indexed citations
20.
Shireman, Jack, Jeea Choi, Scott G. Canfield, et al.. (2019). Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties. Development. 146(13). 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026